About OncoSil Medical
OncoSil Medical is a company based in Sydney (Australia) founded in 2005.. OncoSil Medical offers products and services including OncoSil™. OncoSil Medical operates in a competitive market with competitors including Sana Biotechnology, Janux Therapeutics, Carisma Therapeutics, GigaGen and Kronos Bio, among others.
- Headquarter Sydney, Australia
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oncosil Medical Ltd
-
Annual Revenue
$764.01 K (USD)126.62as on Jun 30, 2025
-
Net Profit
$-9.86 M (USD)-26.74as on Jun 30, 2025
-
EBITDA
$-10.07 M (USD)-18.7as on Jun 30, 2025
-
Latest Funding Round
$8.7 M (USD), Post-IPO
May 26, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of OncoSil Medical
OncoSil Medical is a publicly listed company on the ASX with ticker symbol OSL in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of OncoSil Medical
OncoSil Medical offers a comprehensive portfolio of products and services, including OncoSil™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers targeted radiation to pancreatic tumors with chemotherapy.
Unlock access to complete
Funding Insights of OncoSil Medical
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $8.7M
-
First Round
First Round
(01 Jun 2005)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Post-IPO - OncoSil Medical | Valuation |
investors |
|
| Apr, 2022 | Amount | Post-IPO - OncoSil Medical | Valuation |
investors |
|
| Feb, 2016 | Amount | Post-IPO - OncoSil Medical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OncoSil Medical
OncoSil Medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Regal Funds Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long/short investment strategy is followed by this hedge fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OncoSil Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OncoSil Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncosil Medical Comparisons
Competitors of OncoSil Medical
OncoSil Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Janux Therapeutics, Carisma Therapeutics, GigaGen and Kronos Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer treatment are developed to target solid tumors.
|
|
| domain | founded_year | HQ Location |
Chimeric antigen receptor macrophages are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Antibody-based drugs for primary myopathies are developed and targeted.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncosil Medical
Frequently Asked Questions about OncoSil Medical
When was OncoSil Medical founded?
OncoSil Medical was founded in 2005.
Where is OncoSil Medical located?
OncoSil Medical is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
What is the annual revenue of OncoSil Medical?
Annual revenue of OncoSil Medical is $764.01K as on Jun 30, 2025.
What does OncoSil Medical do?
OncoSil Medical was founded in 2005 in Sydney, Australia, within the medical device sector focused on oncology. Operations center on the development of OncoSil, a brachytherapy implant that delivers beta radiation via phosphorous-32 microparticles to target cancer cell DNA in the pancreas. Proprietary diluents are used as carriers for precise implantation into affected tissues, supporting localized treatment approaches.
Who are the top competitors of OncoSil Medical?
OncoSil Medical's top competitors include Janux Therapeutics, Kronos Bio and Sana Biotechnology.
What products or services does OncoSil Medical offer?
OncoSil Medical offers OncoSil™.
Is OncoSil Medical publicly traded?
Yes, OncoSil Medical is publicly traded on ASX under the ticker symbol OSL.
Who are OncoSil Medical's investors?
OncoSil Medical has 1 investor. Key investors include Regal Funds Management.
What is OncoSil Medical's ticker symbol?
The ticker symbol of OncoSil Medical is OSL on ASX.